Targeting PDK4 inhibits breast cancer metabolism

about

Targeting PDK4 inhibits breast cancer metabolism

Item

http://www.wikidata.org/entity/Q57494133

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Targeting PDK4 inhibits breast cancer metabolism

@en

Targeting PDK4 inhibits breast cancer metabolism

@nl

type

Item

label

Targeting PDK4 inhibits breast cancer metabolism

@en

Targeting PDK4 inhibits breast cancer metabolism

@nl

prefLabel

Targeting PDK4 inhibits breast cancer metabolism

@en

Targeting PDK4 inhibits breast cancer metabolism

@nl

P1476

Targeting PDK4 inhibits breast cancer metabolism

@en

P2093

Andrew J Tsung

http://www.w3.org/2001/XMLSchema#string

Collin M Labak

http://www.w3.org/2001/XMLSchema#string

Durbaka Vr Prasad

http://www.w3.org/2001/XMLSchema#string

Ilya Alexandrov

http://www.w3.org/2001/XMLSchema#string

Kiran K Velpula

http://www.w3.org/2001/XMLSchema#string

Maheedhara R Guda

http://www.w3.org/2001/XMLSchema#string

Malcolm J Mackenzie

http://www.w3.org/2001/XMLSchema#string

Swapna Asuthkar

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs: genomics, biogenesis, mechanism, and function

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

p21 is necessary for the p53-mediated G1 arrest in human cancer cells

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.

HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies.

Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.

Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

P304

1725-1738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323966

http://www.w3.org/2001/XMLSchema#string

P932

6176187

http://www.w3.org/2001/XMLSchema#string